Clinical Trials Show Strong Long-Term Performance with the Medtronic CoreValve TAVR System
March 10, 2018 12:15 ET
|
Medtronic plc
Presented at ACC.18, Five-Year Follow-up from the CoreValve Extreme Risk and NOTION Studies Show Sustained Valve Function and Durability Over Time DUBLIN and ORLANDO - March 10, 2018 - Medtronic...
Zio by iRhythm Shown to Improve Detection of Previously Undiagnosed Atrial Fibrillation
March 10, 2018 12:15 ET
|
iRhythm
SAN FRANCISCO, March 10, 2018 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today...
OCEANTEAM ASA - POSTPONEMENT OF EXTRAORDINARY GENERAL MEETING
March 10, 2018 11:18 ET
|
OceanTeam ASA
Reference is made to Oceanteam ASA's (OSE trading symbol: "OTS") press releases of 9 February and 14 February regarding the plan to solve the Company's auditor issue and notice of an extraordinary...
Larson Electronics LLC Releases 20W Explosion Proof LED Ultraviolet Light
March 10, 2018 11:00 ET
|
Larson Electronics, LLC
KEMP, Texas, March 10, 2018 (GLOBE NEWSWIRE) -- Larson Electronics LLC, leader in industrial lighting, has released an ultraviolet LED light that is explosion proof and approved for use in paint...
The Law Firm of Klayman & Toskes, P.A. Issues an Important Notice to All Customers Who Have Purchased Vehicles or Serviced Vehicles at Ferrari-Maserati of Fort Lauderdale
March 10, 2018 10:30 ET
|
Klayman & Toskes P.A.
BOCA RATON, Fla., March 10, 2018 (GLOBE NEWSWIRE) -- The Law Firm of Klayman & Toskes, P.A., www.nasd-law.com issues an important notice to all customers who have purchased vehicles or serviced...
Sanofi and Regeneron announce plans to make Praluent® more accessible and affordable for patients with the greatest health risk and unmet need
March 10, 2018 09:02 ET
|
Sanofi - Aventis Groupe
Press ReleaseSource: Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi and Regeneron announce plans to make Praluent® more accessible and affordable for patients with the greatest health risk...
Sanofi: Praluent® (alirocumab) significantly reduced risk of cardiovascular events in high-risk patients, and was associated with lower death rate
March 10, 2018 09:00 ET
|
Sanofi - Aventis Groupe
Press ReleaseSource: Sanofi (EURONEXT: SAN) (NYSE: SNY) Praluent® (alirocumab) significantly reduced risk of cardiovascular events in high-risk patients, and was associated with lower...
ALSTOM SA: Alstom completes most powerful all-electric "Make-In-India" locomotive from Madhepura and announces contract wins worth €75 million in India
March 10, 2018 07:00 ET
|
ALSTOM SA
Alstom completes most powerful all-electric...
Palohälytys Fermionin Hangon tehtaalla aamulla - ei henkilö- tai ympäristövahinkoja
March 10, 2018 05:40 ET
|
Orion Oyj
ORION OYJ LEHDISTÖTIEDOTE 10.3.2018 KLO 12.40 Palohälytys Fermionin Hangon tehtaalla aamulla - ei henkilö- tai ympäristövahinkoja Orionin...
WAGEWORKS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Wageworks, Inc. - WAGE
March 09, 2018 22:50 ET
|
Kahn Swick & Foti, LLC
NEW ORLEANS, March 09, 2018 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until...
- June 02, 2024 11:31 ET KFSHRC Successfully Treats Severe Case of "Xanthoma" After 26 Years of Suffering
- June 02, 2024 10:00 ET Nanobiotix Announces New Data Showing Disease Control and Tumor Response in Patients Treated With RT-Activated NBTXR3 Followed By anti-PD-1 For 2l+ R/M HNSCC Naïve or Resistant to Prior anti-PD-1 Therapy